Bridging the Gap: Conference Workbook [International Conference on AIDS (12th: 1994: Geneva, Switzerland)]

Wednesday, July 1

L-OSE SSIOSrckB322 -3235

32322 Strategies to optimise adherence to highly active
antiretroviral treatment
Hernando Knobel*; A. Carmona; S. Grau; P Saballs;.L. Gimeno;
J.L. Lopez Colomes, Spain
32323 Interventions and patient outcome from a pharmacist-based HIV
medication adherence referral clinic
Kathleen Graham*; L.H. Beeler; S. Renae; M.G. Sension, USA
32324 Adherence patterns in patients with symptomatic mycobacterium
avium complex (MAC) infection taking a twice-daily Clarithromycin
regimen
Charles Flexner*; D. Noe; C Benson; J. Currier; A. Andrade; A. Shaver, USA
32325 The impact of the ALRT alarm device on antiretroviral (AR) adherence
among HIV-infected outpatients in Harlem
Sharon Mannheimer*; Y Hirsch; W EI-Sadr, USA
32326 Adherence to currently prescribed antiretroviral therapies:
Results from a multisite interview project
Jeffrey L.Jones*; Allyn K. Nakashima; D.A. Burgess;J. W Ward, USA
32327 Nationwide protease inhibitor adherence program
Julia C Nissen*; Lidia Gajewski; A.J. Grimone; G.J. Vanscoy, USA
32328 Adherence to quadruple therapy with abacavir (1592), amprenavir,
and combivirT in subjects with acute and chronic HIV-1 infection
Priti Jhingran*; S.V. Pham; J.M. Tolson; M.H. Markowitz; R. Kost;
J. Johnson, USA
32329 Antretroviral use and adherence in a cohort of 696 HIV+ pregnant
women
Barbara J. Turner*; CJ. Newschaffer; W W Hauck; D. Zhang; L. Cosler, USA
32330 Saliva as a possible specimen for monitoring compliance and plasma
levels in patients treated with indinavir (IDV)
Patricia W.H. Hugen*; D.M. Burger; R.M. W Hoetelmans; K. Brinkman;
PL. Meenhorst; J.W. Mulder; PP Koopmans, The Netherlands
32331 Attitudes and age are related to adherence to combination
therapy in HIV-1 positive gay men
Jeffrey J. Weiss*; M.H. Antoni; CL. Mulder; B. Garssen, The Netherlands
32332 Bridging the gap between the world of medicine and people living
with HIV/AIDS as prerequisite for good compliance
Max Rohr, Switzerland
32333 Educational and support needs of people living with HIV (PLWH) to
improve adherence to highly active antiretroviral therapy (HAART)
Laureen Kunches*;J.M. Mazzullo; E. Miller-Mack; M. Russell; Z. Ortega,
USA
32334 Highly active antiretroviral therapy (HAART) in the "Real World":
Experiences in an inner-city community health center (CHC)
Lisa Hirschhorn*;J. Quinones; S. Goldin; L. Metros, USA
32335 Why is highly active antiretroviral therapy (HAART) not prescribed
or why is it discontinued - A prospective analysis in the Swiss HIV
cohort study (SHCS)
Stefano Bassetti*; Manuel Battegay; M. Rickenbach; M. Flepp;
H.J. Furrer; A. Telenti; P. Vernazza; E. Bernasconi; P. Sudre, Switzerland
32336 Increasing active drug users' adherence to HIV therapeutics
(supported by the national institute on drug abuse R01 08014)

Robert Broadhead*; D.D. Heckathron; PG. O'Connor; PA. Selwyn, USA

32337 Adherence to protease inhibitor (PI) therapy in clinical practice:
Usefulness of demographics, attitudes and knowledge as predictors
Valerie E. Stone*;J. Adelson-Mitty; C.A. Duefield; K.A. Steger; M.D. Stein;
K.H. Mayer, USA
32338 Self-reported adherence to combination antiretroviral medication
(ARV) regimens in a community-based sample of HIV-infected adults
Allen L. Gifford*; MJ. Shively;J.E. Bormann; D. Timberlake; S.A. Bozzette,
USA
32339 Are there gender differences in HIV adherence?
K.M. Nokes*; I.B. Corless; M.A. Brown; J.G. Turner; G.M. Powell-Cope;
J. Inouye; WL. Holzemer, USA
32340 Furthering compliance with triple antiretroviral therapies:
A common workshop between patients and a ward staff
Mich Gruffaz-Mauris, France
32341 Safety, tolerance and adherence of late oral ZDV to reduce perinatal
HIV transmission, Bangkok
Nathan Shaffer*; Rutt Chuanchoowong; S. Asavapiriyanont;
P Chaisilwattana; N. Wanprapa; V Sangtaweesin;
W Bhanichsupapol; N. Shaffer, Thailand
32342 Determinants of medication adherence in HIV+ women:
A pilot investigation
Ramani Durvasula*; C Golin; M. Stefanik, USA
32343 Improvement in sexual drive and a falling viral load are associated
with adherence to antiretroviral therapy
Robert Pratt*; N. Robinson; H.P Loveday; CM. Pellowe; PJ. Franks;
C Loveday; R. Home, UK
32344 Antiretroviral therapy adherence in Brazil.
An alternative methodological approach of its assessment
Maria Ines B. Nemes*;A. Grangeiro;J.C.B. Pacca; R.A. Souza;
A.O. Kalichman, Brazil
32345 Survey of Pan European attitudes to HIV
Arjen Broekhluzen; European Aids Treatment Group,
The Netherlands, Germany
32346 Social support and adherence in HIV+ persons
Marie-Annette Brown*; J. Inouye; G.M. Powell-Cope;
WL. Holzemer; K.M. Nokes; I.B. Corless; J.G. Turner, USA
32347 Adherence to antiretroviral therapy (ART) among women in
the HIV Epidemiology Research Study (HERS) and Women's
Inter-Agency HIV Study (WIHS)
Suzanne Ohmit*; Paula Schuman; E. SChoenbaum;A. Rompalo;
M. Cohen;J. Richardson; H. Sacks; M. Young, USA
32348 Take as prescribed:a study of adherence behaviours in people taking
antiretroviral medications
Barbara Hedge*;J.A. Petrak, UK
32349 Support intervention to enhance medication adherence
Richard Byrd*; A.E. Fisher; K.M. Melbourne; C. Willey-Lessne;
E. Healey; A.C. Morrill, USA
32350 Virological failure and adherence to antiretroviral therapy in HIVinfected patients
Immaculada Jimenez-Nacher*; R. Rodriguez-Rosado; P Anton;
V. Soriano;J. Gonzalez-Lahoz, Spain

146

12th World AIDS Conference Geneva